TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 29705555

Group type: EXPERIMENTAL
Intervention: DA-9701
Number of subjects: 40

Group type: COMPARATOR
Intervention: Domperidone
Number of subjects: 40
Study: 26375357

Group type: EXPERIMENTAL
Intervention: Approach-chocolate condition
Number of subjects: 120

Group type: COMPARATOR
Intervention: Avoid-chocolate condition
Number of subjects: 120
Study: 24458212

Group type: EXPERIMENTAL
Intervention: High-protein supplementation (HP)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Standard meal supplementation (SM)
Number of subjects: 18
Study: 23019834

Group type: EXPERIMENTAL
Intervention: Zinc sulfate (10 mg/5 mL concentration)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Artificial saliva (control)
Number of subjects: 16
Study: 20937118

Group type: EXPERIMENTAL
Intervention: CAPOX and Bevacizumab
Number of subjects: 0

Group type: COMPARATOR
Intervention: CAPOX alone
Number of subjects: 0
Study: 17215176

Group type: EXPERIMENTAL
Intervention: high-CHO(food+fibre)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: high-CHO(drink+fibre)
Number of subjects: 18

Group type: COMPARATOR
Intervention: high-CHO(food control)
Number of subjects: 18

Group type: COMPARATOR
Intervention: high-CHO(drink control)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: high-CHO breakfasts
Number of subjects: 18
Study: 15266731

Group type: EXPERIMENTAL
Intervention: 30,000 rpm electric rotary drill with irrigation
Number of subjects: 100

Group type: COMPARATOR
Intervention: 90,000 rpm handpiece
Number of subjects: 100
Study: 12578245

Group type: EXPERIMENTAL
Intervention: Children's Effort Rating Table (CERT)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Borg 6-20 Rating of Perceived Exertion (RPE) scale
Number of subjects: 69
Study: 9439022

Group type: EXPERIMENTAL
Intervention: Real acupuncture
Number of subjects: 32

Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 32

Group type: COMPARATOR
Intervention: Mock transcutaneous electrical nerve stimulation
Number of subjects: 32
Study: 8586837

Group type: EXPERIMENTAL
Intervention: HIV-1 infected patients with oral hairy leukoplakia
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Asymptomatic HIV-1 infected persons
Number of subjects: 91

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: HIV-1 infected patients
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Symptomatic HIV-1 infected persons
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: HIV-1 infected patients with and without hairy leukoplakia
Number of subjects: 91
Study: 2670657

Group type: EXPERIMENTAL
Intervention: Perindopril (4 mg o.d.)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Captopril (25 mg b.i.d.)
Number of subjects: 13
Study: 68225

Group type: EXPERIMENTAL
Intervention: Subcuticular polyglycolic acid (P.G.A.) sutures
Number of subjects: 127

Group type: COMPARATOR
Intervention: Interrupted nylon skin sutures
Number of subjects: 127
Study: 31264313

Group type: EXPERIMENTAL
Intervention: 1-g hesperidin capsule
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo capsule
Number of subjects: 50
Study: 27864156

Group type: EXPERIMENTAL
Intervention: Behavior therapy
Number of subjects: 122

Group type: COMPARATOR
Intervention: Supportive psychotherapy
Number of subjects: 122
Study: 26614145

Group type: EXPERIMENTAL
Intervention: Paracetamol
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Dipyrone
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 23728544

Group type: EXPERIMENTAL
Intervention: Easy Bond (3M ESPE) with three adhesive layers
Number of subjects: 90

Group type: COMPARATOR
Intervention: Scotchbond 1XT (3M ESPE) per manufacturer's instructions
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Easy Bond (3M ESPE) with one to four additional adhesive layers
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Scotchbond 1XT (3M ESPE) with three and four layers
Number of subjects: 90
Study: 21609298

Group type: EXPERIMENTAL
Intervention: Decision-support information combined with personal decision-making support (counselling/peer meetings)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Decision-support information only (services/quality indicators)
Number of subjects: 0
Study: 19924244

Group type: EXPERIMENTAL
Intervention: Non-diabetic individuals carrying the T allele of TCF7L2 polymorphism rs7903146
Number of subjects: 889

Group type: EXPERIMENTAL
Intervention: Non-diabetic individuals carrying the CT/TT genotypes
Number of subjects: 889
Study: 16828804

Group type: EXPERIMENTAL
Intervention: Rasagiline 1 mg
Number of subjects: 876

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 876
Study: 12849664

Group type: EXPERIMENTAL
Intervention: Lipid-lowering therapy
Number of subjects: 643

Group type: COMPARATOR
Intervention: No lipid-lowering therapy
Number of subjects: 643
Study: 10980586

Group type: EXPERIMENTAL
Intervention: High intake of saturated fats
Number of subjects: 815

Group type: COMPARATOR
Intervention: Hypertensive subjects
Number of subjects: 815

Group type: COMPARATOR
Intervention: Non-hypertensive subjects
Number of subjects: 815
Study: 8830940

Group type: EXPERIMENTAL
Intervention: 1-h preoxygenation with exercise
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: 15-min preoxygenation with exercise
Number of subjects: 74

Group type: COMPARATOR
Intervention: 1-h resting preoxygenation
Number of subjects: 74
Study: 1521973

Group type: EXPERIMENTAL
Intervention: Preventive intervention group
Number of subjects: 1600

Group type: EXPERIMENTAL
Intervention: Older age
Number of subjects: 1600

Group type: EXPERIMENTAL
Intervention: Nonsingle family residence
Number of subjects: 1600

Group type: EXPERIMENTAL
Intervention: No alcohol use
Number of subjects: 1600

Group type: EXPERIMENTAL
Intervention: Depression
Number of subjects: 1600

Group type: EXPERIMENTAL
Intervention: Group assignment
Number of subjects: 1600
Study: 2866837

Group type: EXPERIMENTAL
Intervention: Flurazepam (30 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Triazolam (0.5 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 29998770

Group type: EXPERIMENTAL
Intervention: Cognitive behavioral planning intervention (six sessions)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Waitlist condition
Number of subjects: 58
Study: 28514320

Group type: EXPERIMENTAL
Intervention: 20 minutes of forced air warming plus intravenous fluid warming
Number of subjects: 50

Group type: COMPARATOR
Intervention: No active preoperative warming plus intravenous fluid warming
Number of subjects: 50
Study: 27870739

Group type: EXPERIMENTAL
Intervention: Angle Labor Pain Questionnaire (A‐LPQ) administered before epidural insertion (Test 1)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Angle Labor Pain Questionnaire (A‐LPQ) administered 20 to 30 minutes after test dose (Test 2)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: A‐LPQ summary scores
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Numeric Rating Scale for overall pain intensity
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Verbal Rating Scale (VRS) scores
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Pain Mastery Scale for coping
Number of subjects: 51
Study: 23671205

Group type: EXPERIMENTAL
Intervention: Increased total cholesterol/HDL
Number of subjects: 413

Group type: EXPERIMENTAL
Intervention: Increased LDL/HDL
Number of subjects: 413

Group type: EXPERIMENTAL
Intervention: Total cholesterol
Number of subjects: 413

Group type: EXPERIMENTAL
Intervention: LDL cholesterol
Number of subjects: 413
Study: 22658477

Group type: EXPERIMENTAL
Intervention: Ketamine 0.15 mg/kg
Number of subjects: 60

Group type: COMPARATOR
Intervention: 0.9% saline (Control)
Number of subjects: 60
Study: 20533147

Group type: EXPERIMENTAL
Intervention: Microcurrent therapy (M)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Sham treatment (S)
Number of subjects: 78
Study: 18544524

Group type: EXPERIMENTAL
Intervention: Landiolol
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Remifentanil
Number of subjects: 60

Group type: COMPARATOR
Intervention: Saline (Control)
Number of subjects: 60
Study: 15286546

Group type: EXPERIMENTAL
Intervention: Sivelestat (0.16 mg.kg(‐1)hr(‐1))
Number of subjects: 492

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 492

Group type: EXPERIMENTAL
Intervention: Sivelestat
Number of subjects: 492
Study: 11195983

Group type: EXPERIMENTAL
Intervention: 1 mg alprazolam
Number of subjects: 67

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 67

Group type: COMPARATOR
Intervention: Nonfearful women
Number of subjects: 67
Study: 9263388

Group type: EXPERIMENTAL
Intervention: Intravenously and orally administered trimethoprim
Number of subjects: 0
Study: 8112375

Group type: EXPERIMENTAL
Intervention: Lovastatin (20 mg per day)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 3771809

Group type: EXPERIMENTAL
Intervention: l-norepinephrine infusion (4 to 16 micrograms/min)
Number of subjects: 6
Study: 30334693

Group type: EXPERIMENTAL
Intervention: VX-659-tezacaftor-ivacaftor
Number of subjects: 0

Group type: COMPARATOR
Intervention: Tezacaftor-ivacaftor
Number of subjects: 0
Study: 27206497

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioural therapy (CBT) preoperative intervention
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group (no CBT intervention)
Number of subjects: 90
Study: 24990275

Group type: EXPERIMENTAL
Intervention: Dark chocolate (40 g, >85% cocoa)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Milk chocolate (40 g, ≤35% cocoa)
Number of subjects: 20
Study: 21131310

Group type: EXPERIMENTAL
Intervention: Cognitive training and cell phone follow-up
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Cognitive training only
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Cognitive training plus cell phone
Number of subjects: 70
Study: 20512062

Group type: EXPERIMENTAL
Intervention: pegylated interferon‐alpha2a
Number of subjects: 114

Group type: COMPARATOR
Intervention: placebo or ribavirin
Number of subjects: 114
Study: 18242883

Group type: EXPERIMENTAL
Intervention: Strengths-based case management (SBCM), n=222
Number of subjects: 678

Group type: EXPERIMENTAL
Intervention: Motivational interviewing (MI), n=226
Number of subjects: 678

Group type: COMPARATOR
Intervention: Standard of care (SOC), n=230
Number of subjects: 678
Study: 16020940

Group type: EXPERIMENTAL
Intervention: Virgin argan oil (VAO) 25 g/day for 3 weeks
Number of subjects: 60

Group type: COMPARATOR
Intervention: Extra virgin olive oil (EVO) 25 g/day for 3 weeks
Number of subjects: 60
Study: 14623832

Group type: EXPERIMENTAL
Intervention: Ice, elevation, Tubigrip, and exercise
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Crutches, early weight bearing, and non-steroidal anti-inflammatory drugs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Rest
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Physiotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Follow up
Number of subjects: 0
Study: 10390254

Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 118

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 118
Study: 8874336

Group type: EXPERIMENTAL
Intervention: Psychologic distress screening program with monthly telephone screening and additional psychosocial intervention for high distress patients
Number of subjects: 282

Group type: COMPARATOR
Intervention: Control group receiving brief psychosocial intervention from a social worker at initial treatment
Number of subjects: 282

Group type: EXPERIMENTAL
Intervention: Experimental group receiving brief psychosocial intervention from a social worker at initial treatment
Number of subjects: 282

Group type: EXPERIMENTAL
Intervention: Minimal psychosocial intervention at initial treatment
Number of subjects: 282
Study: 1997689

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy (4 courses at 28-day intervals of 100 mg/M2 cisplatin, 60 mg/M2 doxorubicin, and 600 mg/M2 cyclophosphamide)
Number of subjects: 91

Group type: COMPARATOR
Intervention: Observation
Number of subjects: 91
Study: 6394405

Group type: EXPERIMENTAL
Intervention: Ionization with diclofenac sodium (150 mg)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo (ionization with saline solution)
Number of subjects: 24
Study: 31971597

Group type: EXPERIMENTAL
Intervention: Presatovir
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 28
Study: 30867067

Group type: EXPERIMENTAL
Intervention: Prebiotic supplementation (10 g/day for healthy subjects, 20 g/day for frail subjects)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (10 g/day maltodextrin)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High-fiber/low-fat diet
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low-fiber/high-fat diet
Number of subjects: 0
Study: 30560096

Group type: EXPERIMENTAL
Intervention: Open supraglottic laryngectomy
Number of subjects: 41

Group type: COMPARATOR
Intervention: Laser supraglottic laryngectomy (CO2 laser)
Number of subjects: 41
Study: 26655559

Group type: EXPERIMENTAL
Intervention: nab-paclitaxel plus gemcitabine (nab-P/Gem)
Number of subjects: 421

Group type: COMPARATOR
Intervention: gemcitabine (Gem)
Number of subjects: 421
Study: 24970377

Group type: EXPERIMENTAL
Intervention: Lifestyle changes including a polyphenol-rich modified Mediterranean diet and physical exercise (30 min/day)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Red wine (100 ml for women, 200 ml for men)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Control group (avoiding alcohol)
Number of subjects: 108
Study: 22516873

Group type: EXPERIMENTAL
Intervention: Continuous ART (arm 1)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sequential ART interruptions (arm 2)
Number of subjects: 0
Study: 19681410

Group type: EXPERIMENTAL
Intervention: Subarachnoid morphine, bupivacaine and fentanyl
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Subarachnoid morphine and bupivacaine
Number of subjects: 60

Group type: COMPARATOR
Intervention: Subarachnoid morphine only
Number of subjects: 60
Study: 17235584

Group type: EXPERIMENTAL
Intervention: Left colectomy combined with radical lymphadenectomy
Number of subjects: 124

Group type: COMPARATOR
Intervention: Conventional left colectomy
Number of subjects: 124
Study: 15129601

Group type: EXPERIMENTAL
Intervention: NTI splint
Number of subjects: 30

Group type: COMPARATOR
Intervention: Stabilisation splint
Number of subjects: 30
Study: 11283049

Group type: EXPERIMENTAL
Intervention: cagA-lacking strain
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: tobacco smoking
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: double dose of proton pump inhibitor
Number of subjects: 156
Study: 9133967

Group type: EXPERIMENTAL
Intervention: Methotrexate (MTX) 15 mg weekly
Number of subjects: 174

Group type: COMPARATOR
Intervention: Gold sodium thiomalate (GSTM) 50 mg weekly
Number of subjects: 174
Study: 12369757

Group type: EXPERIMENTAL
Intervention: Glimepiride 1 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Glimepiride 2 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Glimepiride 4 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Glimepiride 8 mg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Standardised carbohydrate diet
Number of subjects: 12
Study: 12341738

Group type: EXPERIMENTAL
Intervention: TCu 200 IUD with string
Number of subjects: 84

Group type: COMPARATOR
Intervention: TCu 200 IUD without string
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 84
Study: 31986111

Group type: EXPERIMENTAL
Intervention: Additional Rehabilitation after Botulinum Toxin-A
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no additional rehabilitation)
Number of subjects: 0
Study: 30407958

Group type: EXPERIMENTAL
Intervention: Experimental protocol with resuscitation-automating devices and goal-directed algorithmic protocol
Number of subjects: 20

Group type: COMPARATOR
Intervention: Standard protocols and equipment
Number of subjects: 20
Study: 27288384

Group type: EXPERIMENTAL
Intervention: Online intervention (REFRESH)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Leaflet comparator
Number of subjects: 80
Study: 24876490

Group type: EXPERIMENTAL
Intervention: Psychosocial stimulation intervention (weekly visits from community health workers for 2 years)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Nonstunted comparison group (65 participants)
Number of subjects: 105
Study: 22616015

Group type: EXPERIMENTAL
Intervention: Bananas (BAN)
Number of subjects: 14

Group type: COMPARATOR
Intervention: 6% carbohydrate drink (CHO)
Number of subjects: 14
Study: 21092774

Group type: EXPERIMENTAL
Intervention: Thoracic endovascular aortic repair (TEVAR) with optimal medical therapy (n = 72)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Optimal medical therapy (n = 68)
Number of subjects: 140
Study: 18365278

Group type: EXPERIMENTAL
Intervention: Fibrin sealant applied to gastrojejunal and jejunojejunal anastomoses and over mesenteric openings
Number of subjects: 320

Group type: COMPARATOR
Intervention: Control group (no fibrin sealant; suture of the mesenteric openings)
Number of subjects: 320
Study: 15691531

Group type: EXPERIMENTAL
Intervention: TRP-deficient amino acid drink
Number of subjects: 28

Group type: COMPARATOR
Intervention: TRP-supplemented amino acid drink
Number of subjects: 28
Study: 12867220

Group type: EXPERIMENTAL
Intervention: IM fulvestrant 50 mg
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: IM fulvestrant 125 mg
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: IM fulvestrant 250 mg
Number of subjects: 200

Group type: COMPARATOR
Intervention: Oral tamoxifen 20 mg
Number of subjects: 200

Group type: COMPARATOR
Intervention: Oral placebo
Number of subjects: 200
Study: 12906937

Group type: EXPERIMENTAL
Intervention: 5mg prednisolone daily
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 20
Study: 10220832

Group type: EXPERIMENTAL
Intervention: Gly‐X‐Y repeat sequences (active drug)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 7838040

Group type: EXPERIMENTAL
Intervention: Regimen A1 followed by alternating treatment with regimen B and intensified A1 (group 1)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Regimen A1 followed by alternating treatment with regimen C and intensified A1 (group 2)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Supralethal therapy and bone marrow transplantation (BMT) (group 3)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Bone marrow transplantation (BMT)
Number of subjects: 110
Study: 2115044

Group type: EXPERIMENTAL
Intervention: 6 x 100 mg testosterone pellets
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: 6 x 200 mg testosterone pellets
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: 3 x 200 mg testosterone pellets
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: 200 mg testosterone pellets
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Testosterone pellets
Number of subjects: 43
Study: 342729

Group type: EXPERIMENTAL
Intervention: Chenodeoxycholic acid therapy at a dosage of 15 mg/kg/day or more
Number of subjects: 12

Group type: COMPARATOR
Intervention: Chenodeoxycholic acid therapy at a dosage of less than 15 mg/kg/day
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Chenodeoxycholic acid therapy
Number of subjects: 12
Study: 29843840

Group type: EXPERIMENTAL
Intervention: Emergency Department (ED) treatment services
Number of subjects: 115
Study: 27729440

Group type: EXPERIMENTAL
Intervention: Early intervention (Group 1)
Number of subjects: 20000

Group type: COMPARATOR
Intervention: Later intervention (Group 2)
Number of subjects: 20000
Study: 25019269

Group type: EXPERIMENTAL
Intervention: Ranibizumab
Number of subjects: 24

Group type: COMPARATOR
Intervention: Mitomycin C (MMC)
Number of subjects: 24
Study: 23876832

Group type: EXPERIMENTAL
Intervention: Enhanced online weight-loss program
Number of subjects: 301

Group type: COMPARATOR
Intervention: Basic online weight-loss program
Number of subjects: 301
Study: 21991731

Group type: EXPERIMENTAL
Intervention: Intraperitoneal pethidine
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 19212327

Group type: COMPARATOR
Intervention: Indwelling urinary catheter placement (CG)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Non-placement of indwelling urinary catheter (UG)
Number of subjects: 0
Study: 17097276

Group type: EXPERIMENTAL
Intervention: Antipsychotic withdrawal
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Chronic stable antipsychotic treatment
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Medication withdrawal
Number of subjects: 2
Study: 14702509

Group type: EXPERIMENTAL
Intervention: Sodium valproate
Number of subjects: 43

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43
Study: 11704477

Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 43

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43
Study: 9212963

Group type: EXPERIMENTAL
Intervention: Totally roller pumpless CPB system
Number of subjects: 30
Study: 8426406

Group type: EXPERIMENTAL
Intervention: Moxisylyte (10 mg)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Moxisylyte (20 mg)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Moxisylyte (30 mg)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 73
Study: 3119443

Group type: EXPERIMENTAL
Intervention: Transdermal nitroglycerin patch system with discontinuous drug release (7.5 mg/24 hours)
Number of subjects: 10
Study: 31533646

Group type: EXPERIMENTAL
Intervention: Community-led HIV self-testing (HIVST)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard of care (SOC)
Number of subjects: 0
Study: 28703448

Group type: EXPERIMENTAL
Intervention: Brief support
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Hunger training
Number of subjects: 250

Group type: COMPARATOR
Intervention: Control
Number of subjects: 250
Study: 26095190

Group type: EXPERIMENTAL
Intervention: Dulaglutide 1.5 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dulaglutide 0.75 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Exenatide
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: COMPARATOR
Intervention: Metformin
Number of subjects: 0
Study: 24579284

Group type: EXPERIMENTAL
Intervention: PerioBalance (Lactobacilli reuteri‐CFU of 200 million) lozenges for 28 days
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: EvoraKids (Streptococcus uberis KJ2, Streptococcus oralis KJ3, Streptococcus rattus JH1 45, > or = 100 million) probiotics chewable tablets for 30 days
Number of subjects: 60